MiRNA-208a as a sensitive early biomarker for the postoperative course following congenital heart defect surgery
Pediatric Cardiology Jun 15, 2018
Zloto K, et al. - Researchers examined the premise that miRNAs-208a, -208b, and -499 can serve as noninvasive biomarkers for the extent of myocardial damage and the postoperative clinical course of pediatric patients with congenital heart defects (CHDs) at an early time point following surgery. Before and 6, 12, and 24 h after surgery, serum samples were obtained from 79 pediatric patients. It was noted that the levels of the three miRNAs were elevated at 6 h after surgery, remained high at 12 h and declined at 24 h after the operation. The findings demonstrated that circulating miRNA-208a was a predictor for the risk of developing cardiac complications during the postoperative course as early as 6 h after heart surgery for CHD in pediatric patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries